Tag: Zevor-cabtagene autoleucel NMPA approval

Home / Zevor-cabtagene autoleucel NMPA approval

Categories

NMPA approves zevorcabtagene autoleucel CAR T Cell therapy for R/R multiple myeloma

Zevor-Cel therapy Chinese regulators have approved zevorcabtagene autoleucel (zevor-cel; CT053), an autologous CAR T-cell therapy, for the treatment of adult patients with multiple myeloma that has r...
zevor-cabtagene-autoleucel-nmpa-approval

Scan the code